Skip to content

EU · EudraLex Vol.4

EU GMP Annex 1 8.95

8. Production and Specific Technologies › Filter sterilisation of products which cannot be sterilised in their final container

Section text

Where campaign manufacture of a product has been appropriately justified in the CCS and validated, the filter user should:

i. Assess and document the risks associated with the duration of filter use for the sterile filtration process for a given fluid.

ii. Conduct and document effective validation and qualification studies to demonstrate that the duration of filter use for a given sterile filtration process and for a given fluid does not compromise performance of the final sterilising grade filter or filtrate quality.

iii. Document the maximum validated duration of use for the filter and implement controls to ensure that filters are not used beyond the validated maximum duration. Records of these controls should be maintained.

iv. Implement controls to ensure that filters contaminated with fluid or cleaning agent residues, or considered defective in any other way, are removed from use.

Source: European Commission, DG SANTE · © European Union. Reuse is authorised provided the source is acknowledged (Commission Decision 2011/833/EU on the reuse of Commission documents). · retrieved 2026-11-15

Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.